2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
A

2020 ASCO Update on R/M ACC Management: What Is the Efficacy & Toxicity Tolerance of Axitinib?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Anterpreet Neki
By 2020 ASCO Virtual Direct™ Highlights FEATURING Anterpreet Neki
3 views
January 5, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

19:51
AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Mainten…

Feat. D. Czel, C. Arn
Head&Neck
05:57
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on HRAS-Mutant HNSCC: Does Tipifarnib Show Treatmen…

Feat. A. Neki
08:02
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Oropharynx Cancer: Is Transoral Resecti…

Feat. A. Neki
07:53
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on R/M ACC Management: What Is the Efficacy & T…

Feat. A. Neki
09:04
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on SCCHN Management: Is Weekly CDDP + RT More Benef…

Feat. A. Neki